Avindra Nath MD
Clinical Director, National Institute of Neurological Disorders and Stroke (NINDS); Chief, Section of Infections of the Nervous System, National Institutes of Health, Bethesda, MarylandDr. Avindra Nath is a physician–scientist who specializes in the field of neuro-immunology and neurovirology. His research is focused on the clinical manifestations, pathophysiology and treatment of emerging neurological infections with a focus on HIV infection. In recent years, he has studied the neurological complications of endogenous retroviruses, Ebola, Zika virus, and SARS-CoV-2, and he conducts research on patients with undiagnosed neuroinflammatory disorders. He is internationally recognized for his contributions and has served on advisory committees to the NIH, CDC, FDA, and WHO.
Dr. Nath is the Clinical Director of the National Institute of Neurological Disorders and Stroke (NINDS) at NIH, where he is also Chief of the Section of Infections of the Nervous System, Director of the Translational Center for Neurological Sciences, and Director of the Neuroimmunology and Neurovirology Fellowship Program.
Disclosures
- Advisory boards: National Institutes of Health; Centers for Disease Control; Food and Drug Administration; World Health Organization
Recent Contributions to PracticeUpdate:
- Serum Biomarker Profiles Differentiate Between AQP4-Seropositive and Double-Seronegative NMOSD
- 2023 Top Story in Neurology: Advancements in the Diagnosis of MOGAD and MS
- Association Between Viral Exposures and Neurodegenerative Disease Risk
- 2022 Top Story in Neurology: Multiple Sclerosis—The Tale of Two Viruses
- Diagnosis of Secondary Progressive Multiple Sclerosis
- 2021 Top Story in Neurology: Neuroinfectious Diseases and Neuroimmunology
- The BEE Disease and Multiple Sclerosis Diagnosis Dilemma
- Disease Modifying Therapies and SARS-CoV-2 mRNA Vaccine Effects in Patients With MS
- Neurobiology of COVID-19
- Dysregulation of Brain and Choroid Plexus Cell Types in Severe COVID-19